Kathryn Jean Boor - Director at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SRPT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kathryn Jean Boor since 07 Jan 2025

Holdings reported by Kathryn Jean Boor for Sarepta Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,263 $827,374 $100.13 10 Mar 2025 Direct
Stock Options (right to buy) 4,792 10 Mar 2025 Direct Common Stock

Transactions reported by Kathryn Jean Boor for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.